asa glp-1 🔸 Should RAs be continued preprocedurally? 🔸 Who should stop a GLP-1 RA preoperatively? 🔸 Which patients should have their procedures postponed? Read: https://doi.org/10.1097/01.ASM.0001125664.22893.9f GLP-1-based meds linked to fewer

Berberina ultrapura: al menos un 97% de clorhidrato de berberina puro

Retatrutide is administered as a once-weekly subcutaneous injection

The SUSTAIN programme, which evaluated semaglutide at lower doses (0.5 mg and 1.0 mg) for diabetes, generated several years of continuous-use safety data

Langer and colleagues, in a March 2026 Cell Reports Medicine paper combining four preclinical mouse studies with a proof-of-concept clinical trial, performed what may be the first published direct measurement of muscle function alongside body composition in patients on a GLP-1 RA

Evolution of sodium-glucose co-transporter 2 inhibitors from a glucose-lowering drug to a pivotal therapeutic agent for cardio-renal-metabolic syndrome